Study confirms increased heart attack deaths in NYC ambulance ...(RMS annual meeting in Washington DC. ...),Health
Navigation Links
Study confirms increased heart attack deaths in NYC ambulance diversions
Date:11/10/2008
RMS annual meeting in Washington, DC.
'/>"/>
| Contact: Barry List barry.list@informs.org 443-757-3560 Institute for Operations Research and the Management Sciences Source:Eurekalert |
Related medicine news :
1. Study improves recovery for mothers with depression
2. Companies Pay a High Price for Employees With Crohns Disease and Ulcerative Colitis, According to Study From Thomson Reuters
3. Study Finds Rise in Rate of Diagnostic Imaging in Managed Care
4. Study finds rise in rate of diagnostic imaging in managed care
5. Overnight Dialysis Saves Lives: Study
6. Superbugs on the rise in Canadian hospitals, new Queens study shows
7. First Study of War-Related Mental Disorders Among Iraqis 10 Years Post-Gulf War Published by Researchers at Wayne State University and Basrah University, Iraq
8. University of Minnesota Study Says Students Eat More Whole Grains When Gradually Added to School Foods
9. Childrens Hospital study demonstrates how bone marrow transplant can cure sickle cell disease
10. Study shows testosterone improves sexual well-being in post-menopausal women
11. New Study Reveals What Women Want When Considering Cosmetic Procedures
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Harris Williams & Co. Advises Verathon Inc. in its Sale to Strategic Buyer Roper Industries 2Health News:Harris Williams & Co. Advises Verathon Inc. in its Sale to Strategic Buyer Roper Industries 3Health News:Cohen Independent Research Group Issues a 'Buy' Rating With a Target Price of $2.48 for VHGI; 8K filed regarding $50,000,000.00 Treasure Gulch Gold Reserves 2Health News:Cohen Independent Research Group Issues a 'Buy' Rating With a Target Price of $2.48 for VHGI; 8K filed regarding $50,000,000.00 Treasure Gulch Gold Reserves 3Health News:Cohen Independent Research Group Issues a 'Buy' Rating With a Target Price of $2.48 for VHGI; 8K filed regarding $50,000,000.00 Treasure Gulch Gold Reserves 4Health News:Cohen Independent Research Group Issues a 'Buy' Rating With a Target Price of $2.48 for VHGI; 8K filed regarding $50,000,000.00 Treasure Gulch Gold Reserves 5Health News:Despite Early Uptake, Seasonal Flu Vaccination Rates are Similar to Last Year 2Health News:Despite Early Uptake, Seasonal Flu Vaccination Rates are Similar to Last Year 3Health News:Despite Early Uptake, Seasonal Flu Vaccination Rates are Similar to Last Year 4Health News:Despite Early Uptake, Seasonal Flu Vaccination Rates are Similar to Last Year 5Health News:NCCN Guidelines for Non-Small Cell Lung Cancer Updated to Incorporate Maintenance Therapy 2Health News:NCCN Guidelines for Non-Small Cell Lung Cancer Updated to Incorporate Maintenance Therapy 3Health News:AIUM gears up for 2010 Annual Convention in San Diego, Calif. 2
[0] Harris Williams & Co. Advises Verathon Inc. in its Sale to Strategic Buyer Roper Industries [0] Cohen Independent Research Group Issues a 'Buy' Rating With a Target Price of $2.48 for VHGI; 8K filed regarding $50,000,000.00 Treasure Gulch Gold Reserves[0] Despite Early Uptake, Seasonal Flu Vaccination Rates are Similar to Last Year[0] NCCN Guidelines for Non-Small Cell Lung Cancer Updated to Incorporate Maintenance Therapy[0] AIUM gears up for 2010 Annual Convention in San Diego, Calif.
Other Medicine News:Health News:GI Condition Once Thought Rare is Common in U.S. 2Health News:GI Condition Once Thought Rare is Common in U.S. 3Health News:Mission Pharmacal Celebrates Historic Milestone 2Health News:Transdel Pharmaceuticals, Inc. Retains FLP Pharma to Lead Business Development Activities 2Health News:Transdel Pharmaceuticals, Inc. Retains FLP Pharma to Lead Business Development Activities 3Health News:Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc. 2Health News:Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc. 3Health News:Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc. 4Health News:Maximum Potential Offers Affordable Training Course for Parents of Children with Autism 2Health News:MDS Announces Formation of Special Committee 2
GI Condition Once Thought Rare is Common in U.S.Mission Pharmacal Celebrates Historic MilestoneTransdel Pharmaceuticals, Inc. Retains FLP Pharma to Lead Business Development ActivitiesTranscept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc.Maximum Potential Offers Affordable Training Course for Parents of Children with AutismMDS Announces Formation of Special Committee
Breaking Medicine Technology:National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards 2PRA International Hosts an Infectious Diseases Audio Conference 2PRA International Hosts an Infectious Diseases Audio Conference 3Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3Pioneer 28R 29 Surgical Technology Inc Receives Prestigious Spine Technology Awards 6722 1Pioneer 28R 29 Surgical Technology Inc Receives Prestigious Spine Technology Awards 6722 2Upsher Smith Announces Milestone in Development of CNS Strategy 6718 1Upsher Smith Announces Milestone in Development of CNS Strategy 6718 2Honeywell and Pro Lab Sign Distribution Agreement for Laboratory Chemicals in Turkey 6714 1Honeywell and Pro Lab Sign Distribution Agreement for Laboratory Chemicals in Turkey 6714 2Honeywell and Pro Lab Sign Distribution Agreement for Laboratory Chemicals in Turkey 6714 3
[0] National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards[0] PRA International Hosts an Infectious Diseases Audio Conference[0] Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock
Other Medicine Technology:Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 7Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 8Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 9California Stem Cell Agency Exaggerated Its Role in Funding Key Research 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |